| Filed On | Filing |
|---|---|
| 29 Sep 2026 |
Form 4: 3D Investment Partners Pte. Ltd., Formerly 10% Owner and 1 other
Sold 640,000 shares ($1.73M) |
| 29 Sep 2026 | SCHEDULE 13D/A |
| 28 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
On September 23, 2026, MediciNova, Inc. (the “Company”) amended its Lease (the “Lease”), dated July 20, 2021, between the Company and the Irvine Company LLC pursuant to a First Amendment to the Lease, dated as of September 23, 2026 (the ... |
| 02 Sep 2026 | 8-K: Termination of a Material Definitive Agreement |
| 19 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 13 Aug 2026 | 10-Q |
| 25 Jun 2026 |
Form 4: Nagao Hideki, Director
Granted 44,500 Stock Option (Right to Buy) |
| 25 Jun 2026 |
Form 4: Lemerond Nicole, Director
Granted 44,500 Stock Option (Right to Buy) |
| 25 Jun 2026 |
Form 4: Beaver Carolyn, Director
Granted 44,500 Stock Option (Right to Buy) |
| 24 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 14 May 2026 | 10-Q |
| 29 Apr 2026 | ARS |
| 29 Apr 2026 | DEF 14A |
| 29 Apr 2026 | DEFA14A |
| 20 Apr 2026 | PRER14A |
| 17 Apr 2026 | PRE 14A |
| 10 Mar 2026 | 10-K |
| 20 Feb 2026 | 8-K: Results of Operations and Financial Condition |
| 20 Jan 2026 |
Form 4: Matsuda Kazuko, Chief Medical Officer
Granted 350,000 Employee Stock Option (Right to Buy) |
| 20 Jan 2026 |
Form 4: Iwaki Yuichi, President and CEO
Granted 450,000 Employee Stock Option (Right to Buy) |
Loading...
